NUMBERS FOR MRCOG PART 2 EXAM QUESTIONS AND ANSWERS 2026 VERIFIED.

NUMBERS FOR MRCOG PART 2 EXAM
QUESTIONS AND ANSWERS 2026
VERIFIED.




Success rate of VBAC with fetal macrosomia (>4kg) - ANS 50%


Rupture rate of VBAC with fetal macrosomia (>4kg) - ANS 3.6%


Reduction in respiratory morbidity if prophylactic bethamethasone is given beyond 37+0 weeks
of gestation - ANS 50% reduction


reduction of transient tachypnoea in newborn if ERCS delayed from 38 to 39 weeks - ANS 5%


increase risk of antepartum stillbirth if ERCS delayed from 38 to 39 weeks - ANS 0.05%


?-fold increase in uterine rupture in induced and/or augmented VBAC labour compared to
spontaneous VBAC labour - ANS 2-3x


?-fold increase in EMCS in induced and/or augmented VBAC labour compared to spontaneous
VBAC labour - ANS 1.5x


proportion of of uterine rupture during labour - ANS 90%, peak 4-5cm dilatation



@2026/2027 ALLRIGHTS RESERVED.

, proportion of uterine rupture during second stage - ANS 18%


proportion of uterine rupture post vaginal delivery - ANS 8%


Success rate of planned VBAC - ANS 72-75%


Risk of uterine rupture in VBAC - ANS 0.5%


Risk of OASI in VBAC - ANS 5%


Risk of maternal death in VBAC - ANS 4 in 100,000


Risk of TTN in VBAC - ANS 2-3%


Risk of antepartum stillbirth in VBAC - ANS 0.1%


Risk of HIB in VBAC - ANS 0.08%


Risk of delivery related perinatal death in VBAC - ANS 0.04%


Risk of maternal death in ERCS - ANS 13 in 100,000


Risk of TTN in ERCS >38/40 - ANS 4-5%


Risk of TTN in ERCS >38/40 - ANS 6%


Risk of delivery related perinatal death or HIE in ERCS - ANS <0.01%

@2026/2027 ALLRIGHTS RESERVED.